Wang J, Lin R, Zhang W, Li L, Gottstein B, Blagosklonov O, et al. Transcriptional profiles of cytokine/chemokine factors of immune cell-homing to the parasitic lesions: a comprehensive one-year course study in the liver of E. multilocularis-infected mice. PLoS One. 2014. 9(3):e91638. [QxMD MEDLINE Link]. [Full Text].
Wang J, Zhang C, Wei X, Blagosklonov O, Lv G, Lu X, et al. TGF-ß and TGF-ß/Smad signaling in the interactions between Echinococcus multilocularis and its hosts. PLoS One. 2013. 8(2):e55379. [QxMD MEDLINE Link]. [Full Text].
Wang J, Jebbawi F, Bellanger AP, Beldi G, Millon L, Gottstein B. Immunotherapy of alveolar echinococcosis via PD-1/PD-L1 immune checkpoint blockade in mice. Parasite Immunol. 2018. 40:e12596. [QxMD MEDLINE Link].
Zhang C, Shao Y, Yang S, Bi X, Li L, Wang H, et al. T-cell tolerance and exhaustion in the clearance of Echinococcus multilocularis: role of inoculum size in a quantitative hepatic experimental model. Sci Rep. 2018. 7:11153. [QxMD MEDLINE Link].
Massolo A, Liccioli S, Budke C, Klein C. Echinococcus multilocularis in North America: the great unknown. Parasite. 2014. 21:73. [QxMD MEDLINE Link]. [Full Text].
Piarroux M, Piarroux R, Giorgi R, et al. Clinical features and evolution of alveolar echinococcosis in France from 1982 to 2007: Results of a survey in 387 patients. J Hepatol. 2011 Nov. 55(5):1025-33. [QxMD MEDLINE Link].
Bresson-Hadni S, Vuitton DA, Bartholomot B, Heyd B, Godart D, Meyer JP, et al. A twenty-year history of alveolar echinococcosis: analysis of a series of 117 patients from eastern France. Eur J Gastroenterol Hepatol. 2000 Mar. 12(3):327-36. [QxMD MEDLINE Link].
Torgerson PR, Schweiger A, Deplazes P, Pohar M, Reichen J, Ammann RW, et al. Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol. 2008 Jul. 49(1):72-7. [QxMD MEDLINE Link].
Aji T, Dong JH, Shao YM, Zhao JM, Li T, Tuxun T, et al. Ex vivo liver resection and autotransplantation as alternative to allotransplantation for end-stage hepatic alveolar echinococcosis. J Hepatol. 2018. 69:[QxMD MEDLINE Link].
Bresson-Hadni S, Blagosklonov O, Knapp J, Grenouillet F, Sako Y, Delabrousse E, et al. Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study. Liver Transpl. 2011 Jul. 17 (7):855-65. [QxMD MEDLINE Link].
Aydinli B, Ozturk G, Arslan S, Kantarci M, Tan O, Ahıskalioglu A, et al. Liver transplantation for alveolar echinococcosis in an endemic region. Liver Transpl. 2015. 21:1096-102. [QxMD MEDLINE Link].
Kern P, Menezes da Silva A, Akhan O, Müllhaupt B, Vizcaychipi KA, Budke C, et al. The Echinococcoses: Diagnosis, Clinical Management and Burden of Disease. Adv Parasitol. 2017. 96:259-369. [QxMD MEDLINE Link].
Piarroux M, Piarroux R, Knapp J, Bardonnet K, Dumortier J, Watelet J, et al. Populations at risk for alveolar echinococcosis, France. Emerg Infect Dis. 2013 May. 19(5):721-8. [QxMD MEDLINE Link]. [Full Text].
Chauchet A, Grenouillet F, Knapp J, Richou C, Delabrousse E, Dentan C, et al. Increased incidence and characteristics of alveolar echinococcosis in patients with immunosuppression-associated conditions. Clin Infect Dis. 2014 Oct 15. 59(8):1095-104. [QxMD MEDLINE Link].
27th World Congress of Echinococcosis, Algiers, Oct 4-7, 2017. Available at https://cnr-echinococcoses-ccoms.univ-fcomte.fr/spip.php?article170&lang=fr.
Liu W, Delabrousse É, Blagosklonov O, Wang J, Zeng H, Jiang Y, et al. Innovation in hepatic alveolar echinococcosis imaging: best use of old tools, and necessary evaluation of new ones. Parasite. 2014. 21:74. [QxMD MEDLINE Link]. [Full Text].
Kratzer W, Gruener B, Kaltenbach TE, Ansari-Bitzenberger S, Kern P, Fuchs M, et al. Proposal of an ultrasonographic classification for hepatic alveolar echinococcosis: Echinococcosis multilocularis Ulm classification-ultrasound. World J Gastroenterol. 2015 Nov 21. 21 (43):12392-402. [QxMD MEDLINE Link].
Graeter T, Kratzer W, Oeztuerk S, Haenle MM, Mason RA, Hillenbrand A, et al. Proposal of a computed tomography classification for hepatic alveolar echinococcosis. World J Gastroenterol. 2016 Apr 7. 22 (13):3621-31. [QxMD MEDLINE Link].
Brumpt E, Blagosklonov O, Calame P, Bresson-Hadni S, Vuitton DA, Delabrousse E. AE hepatic lesions: correlation between calcifications at CT and FDG-PET/CT metabolic activity. Infection. 2019 Jun 4. in press. [QxMD MEDLINE Link].
Kodama Y, Fujita N, Shimizu T, Endo H, Nambu T, Sato N, et al. Alveolar echinococcosis: MR findings in the liver. Radiology. 2003 Jul. 228(1):172-7. [QxMD MEDLINE Link].
Tamarozzi F, Vuitton L, Brunetti E, Vuitton DA, Koch S. Non-surgical and non-chemical attempts to treat echinococcosis: do they work?. Parasite. 2014. 21:75. [QxMD MEDLINE Link]. [Full Text].
Caoduro C, Porot C, Vuitton DA, Bresson-Hadni S, Grenouillet F, Richou C, et al. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. J Nucl Med. 2013 Mar. 54(3):358-63. [QxMD MEDLINE Link].
Azizi A, Blagosklonov O, Lounis A, Berthet L, Vuitton DA, Bresson-Hadni S, et al. Alveolar echinococcosis: correlation between hepatic MRI findings and FDG-PET/CT metabolic activity. Abdom Imaging. 2015 Jan. 40(1):56-63. [QxMD MEDLINE Link].
Barth TF, Herrmann TS, Tappe D, Stark L, Grüner B, Buttenschoen K, et al. Sensitive and specific immunohistochemical diagnosis of human alveolar echinococcosis with the monoclonal antibody Em2G11. PLoS Negl Trop Dis. 2012. 6 (10):e1877. [QxMD MEDLINE Link].
Vuitton DA, Azizi A, Richou C, Vuitton L, Blagosklonov O, Delabrousse E, et al. Current interventional strategy for the treatment of hepatic alveolar echinococcosis. Expert Rev Anti Infect Ther. 2016 Dec. 14 (12):1179-1194. [QxMD MEDLINE Link].
Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, et al. Echinococcosis: Advances in the 21st Century. Clin Microbio Rev. 2019. 32:e00075-18. [QxMD MEDLINE Link].
Brunetti E, Kern P, Vuitton DA. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2009 Nov 18. [QxMD MEDLINE Link].
Joliat GR, Melloul E, Petermann D, Demartines N, Gillet M, Uldry E, et al. Outcomes After Liver Resection for Hepatic Alveolar Echinococcosis: A Single-Center Cohort Study. World J Surg. 2015 Oct. 39 (10):2529-34. [QxMD MEDLINE Link].
Hillenbrand A, Gruener B, Kratzer W, Kern P, Graeter T, Barth TF, et al. Impact of Safe Distance on Long-Term Outcome After Surgical Therapy of Alveolar Echinococcosis. World J Surg. 2017 Apr. 41 (4):1012-1018. [QxMD MEDLINE Link].
Mantion GA, Vuitton DA. Auto-versus allo-transplantation of the liver for end-stage alveolar echinococcosis?. Chin Med J (Engl). 2011 Sep. 124(18):2803-5. [QxMD MEDLINE Link].
Wen H, Dong JH, Zhang JH, Duan WD, Zhao JM, Liang YR, et al. Ex Vivo Liver Resection and Autotransplantation for End-Stage Alveolar Echinococcosis: A Case Series. Am J Transplant. 2016 Feb. 16 (2):615-24. [QxMD MEDLINE Link].
Ambregna S, Koch S, Sulz MC, et al. A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosis. Expert Rev Anti Infect Ther. 2017 Jan. 15 (1):79-88. [QxMD MEDLINE Link].
Knapp J, Millon L, Mouzon L, Umhang G, Raoul F, Ali ZS, et al. Real time PCR to detect the environmental faecal contamination by Echinococcus multilocularis from red fox stools. Vet Parasitol. 2014 Mar 17. 201 (1-2):40-7. [QxMD MEDLINE Link].
Umhang G, Bastien M, Renault C, Faisse M, Caillot C, Boucher JM, et al. A flotation/sieving method to detect Echinococcus multilocularis and Toxocara spp. eggs in soil by real-time PCR. Parasite. 2017. 24:28. [QxMD MEDLINE Link].
Dinkel A, Kern S, Brinker A, Oehme R, Vaniscotte A, Giraudoux P, et al. A real-time multiplex-nested PCR system for coprological diagnosis of Echinococcus multilocularis and host species. Parasitol Res. 2011 Aug. 109 (2):493-8. [QxMD MEDLINE Link].
Poulle ML, Bastien M, Richard Y, Josse-Dupuis É, Aubert D, Villena I, et al. Detection of Echinococcus multilocularis and other foodborne parasites in fox, cat and dog faeces collected in kitchen gardens in a highly endemic area for alveolar echinococcosis. Parasite. 2017. 24:29. [QxMD MEDLINE Link].
Umhang G, Lahoreau J, Hormaz V, Boucher JM, Guenon A, Montange D, et al. Surveillance and management of Echinococcus multilocularis in a wildlife park. Parasitol Int. 2016 Jun. 65 (3):245-50. [QxMD MEDLINE Link].
Federer K, Armua-Fernandez MT, Gori F, Hoby S, Wenker C, Deplazes P. Detection of taeniid (Taenia spp., Echinococcus spp.) eggs contaminating vegetables and fruits sold in European markets and the risk for metacestode infections in captive primates. Int J Parasitol Parasites Wildl. 2016 Dec. 5 (3):249-53. [QxMD MEDLINE Link].
Knapp J, Damy S, Brillaud J, Tissot JD, Navion J, Mélior R, et al. EWET: Data collection and interface for the genetic analysis of Echinococcus multilocularis based on EmsB microsatellite. PLoS One. 2017. 12 (10):e0183849. [QxMD MEDLINE Link].
Bethony JM, Cole RN, Guo X, Kamhawi S, Lightowlers MW, Loukas A, et al. Vaccines to combat the neglected tropical diseases. Immunol Rev. 2011 Jan. 239 (1):237-70. [QxMD MEDLINE Link].
Gauci C, Merli M, Muller V, Chow C, Yagi K, Mackenstedt U, et al. Molecular cloning of a vaccine antigen against infection with the larval stage of Echinococcus multilocularis. Infect Immun. 2002 Jul. 70 (7):3969-72. [QxMD MEDLINE Link].
Gottstein B, Stojkovic M, Vuitton DA, Millon L, Marcinkute A, Deplazes P. Threat of alveolar echinococcosis to public health--a challenge for Europe. Trends Parasitol. 2015 Sep. 31 (9):407-12. [QxMD MEDLINE Link].
Comte S, Raton V, Raoul F, Hegglin D, Giraudoux P, Deplazes P, et al. Fox baiting against Echinococcus multilocularis: contrasted achievements among two medium size cities. Prev Vet Med. 2013 Aug 1. 111 (1-2):147-55. [QxMD MEDLINE Link].
Romig T, Deplazes P, Jenkins D, Giraudoux P, Massolo A, Craig PS, et al. Ecology and Life Cycle Patterns of Echinococcus Species. Adv Parasitol. 2017. 95:213-314. [QxMD MEDLINE Link].
[Guideline] WHO Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis. Bull World Health Organ. 1996. 74(3):231-42. [QxMD MEDLINE Link]. [Full Text].
[Guideline] Brunetti E, Kern P, Vuitton DA, Writing Panel for the WHO-IWGE. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010 Apr. 114 (1):1-16. [QxMD MEDLINE Link].
Ammann R, Tschudi K, von Ziegler M, Meister F, Cotting J, Eckert J, et al. [The long-term course of 60 patients with alveolar echinococcosis in continuous therapy with mebendazole (1976-85)]. Klin Wochenschr. 1988 Nov 1. 66(21):1060-73. [QxMD MEDLINE Link].
Ammann RW, Eckert J. Cestodes. Echinococcus. Gastroenterol Clin North Am. 1996 Sep. 25(3):655-89. [QxMD MEDLINE Link].
Ammann RW, Hirsbrunner R, Cotting J, Steiger U, Jacquier P, Eckert J. Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis (preliminary results). Am J Trop Med Hyg. 1990 Nov. 43(5):506-15. [QxMD MEDLINE Link].
Auer H, Aspock H. Incidence, prevalence and geographic distribution of human alveolar echinococcosis in Austria from 1854 to 1990. Parasitol Res. 1991. 77(5):430-6. [QxMD MEDLINE Link].
Bart JM, Knapp J, Gottstein B, El-Garch F, Giraudoux P, Glowatzki ML, et al. EmsB, a tandem repeated multi-loci microsatellite, new tool to investigate the genetic diversity of Echinococcus multilocularis. Infect Genet Evol. 2006 Sep. 6(5):390-400. [QxMD MEDLINE Link].
Bart JM, Piarroux M, Sako Y, Grenouillet F, Bresson-Hadni S, Piarroux R. Comparison of several commercial serologic kits and Em18 serology for detection of human alveolar echinococcosis. Diagn Microbiol Infect Dis. 2007 Sep. 59(1):93-5. [QxMD MEDLINE Link].
Bartholomot G, Vuitton DA, Harraga S, Shi DZ, Giraudoux P, Barnish G, et al. Combined ultrasound and serologic screening for hepatic alveolar echinococcosis in central China. Am J Trop Med Hyg. 2002 Jan. 66(1):23-9. [QxMD MEDLINE Link].
Bresson-Hadni S, Beurton I, Bartholomot B, Vuitton DA, Kern P, Mantion G, et al. Alveolar echinococcosis. Hepatology. 1998 May. 27(5):1453-6. [QxMD MEDLINE Link].
Bresson-Hadni S, Delabrousse E, Blagosklonov O, Bartholomot B, Koch S, Miguet JP, et al. Imaging aspects and non-surgical interventional treatment in human alveolar echinococcosis. Parasitol Int. 2006. 55 Suppl:S267-72. [QxMD MEDLINE Link].
Bresson-Hadni S, Humbert P, Paintaud G, Auer H, Lenys D, Laurent R. Skin localization of alveolar echinococcosis of the liver. J Am Acad Dermatol. 1996 May. 34(5 Pt 2):873-7. [QxMD MEDLINE Link].
Bresson-Hadni S, Koch S, Beurton I, Vuitton DA, Bartholomot B, Hrusovsky S, et al. Primary disease recurrence after liver transplantation for alveolar echinococcosis: long-term evaluation in 15 patients. Hepatology. 1999 Oct. 30(4):857-64. [QxMD MEDLINE Link].
Bresson-Hadni S, Laplante JJ, Lenys D, Rohmer P, Gottstein B, Jacquier P, et al. Seroepidemiologic screening of Echinococcus multilocularis infection in a European area endemic for alveolar echinococcosis. Am J Trop Med Hyg. 1994 Dec. 51(6):837-46. [QxMD MEDLINE Link].
Bresson-Hadni S, Liance M, Meyer JP, Houin R, Bresson JL, Vuitton DA. Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin Exp Immunol. 1990 Nov. 82(2):378-83. [QxMD MEDLINE Link].
Bresson-Hadni S, Miguet JP, Lenys D, Vuitton DA, Viennet G, Becker MC, et al. Recurrence of alveolar echinococcosis in the liver graft after liver transplantation. Hepatology. 1992 Jul. 16(1):279-80. [QxMD MEDLINE Link].
Bresson-Hadni S, Vuitton D, Didier D, Etievent JP, Mantion G, Miguet JP, et al. [Pulmonary metastasis of alveolar echinococcosis. Frequency and mechanisms of occurrence]. Presse Med. 1989 Jan 21. 18(2):83. [QxMD MEDLINE Link].
Bresson-Hadni S, Vuitton DA, Lenys D, Liance M, Racadot E, Miguet JP. Cellular immune response in Echinococcus multilocularis infection in humans. I. Lymphocyte reactivity to Echinococcus antigens in patients with alveolar echinococcosis. Clin Exp Immunol. 1989 Oct. 78(1):61-6. [QxMD MEDLINE Link].
Budke CM, Jiamin Q, Qian W, Torgerson PR. Economic effects of echinococcosis in a disease-endemic region of the Tibetan Plateau. Am J Trop Med Hyg. 2005 Jul. 73(1):2-10. [QxMD MEDLINE Link].
Budke CM, Jiamin Q, Zinsstag J, Qian W, Torgerson PR. Use of disability adjusted life years in the estimation of the disease burden of echinococcosis for a high endemic region of the Tibetan plateau. Am J Trop Med Hyg. 2004 Jul. 71(1):56-64. [QxMD MEDLINE Link].
Claudon M, Bessieres M, Regent D, Rodde A, Bazin C, Gerard A, et al. Alveolar echinococcosis of the liver: MR findings. J Comput Assist Tomogr. 1990 Jul-Aug. 14(4):608-14. [QxMD MEDLINE Link].
Claudon M, Chaulieu C, Delgoffe C, Desplechain C, Thomas D, Regent D. [Role of echography in the diagnosis and monitoring of hepatic alveolar echinococcosis]. J Radiol. 1984 Nov. 65(11):773-80. [QxMD MEDLINE Link].
Claudon M, Regent D, Delgoffe C, Bernard C, Gerard A, Treheux A. [Role of computed tomography in the diagnosis and surveillance of hepatic alveolar echinococcosis]. J Radiol. 1985 Aug-Sep. 66(8-9):507-13. [QxMD MEDLINE Link].
Craig PS. Echinococcus granulosus: immunodiagnosis and vaccination, a perspective. Parassitologia. 1997 Dec. 39(4):345-7. [QxMD MEDLINE Link].
Craig PS, Deshan L, MacPherson CN, Dazhong S, Reynolds D, Barnish G, et al. A large focus of alveolar echinococcosis in central China. Lancet. 1992 Oct 3. 340(8823):826-31. [QxMD MEDLINE Link].
Craig PS, Li T, Qiu J, Zhen R, Wang Q, Giraudoux P, et al. Echinococcosis and Tibetan communities. Emerg Infect Dis. 2008 Oct. 14(10):1674-5. [QxMD MEDLINE Link]. [Full Text].
Craig PS, Rogan MT, Campos-Ponce M. Echinococcosis: disease, detection and transmission. Parasitology. 2003. 127 Suppl:S5-20. [QxMD MEDLINE Link].
Deplazes P, Eckert J. Diagnosis of the Echinococcus multilocularis infection in final hosts. Appl Parasitol. 1996 Dec. 37(4):245-52. [QxMD MEDLINE Link].
Didier D, Weiler S, Rohmer P, Lassegue A, Deschamps JP, Vuitton D, et al. Hepatic alveolar echinococcosis: correlative US and CT study. Radiology. 1985 Jan. 154(1):179-86. [QxMD MEDLINE Link].
Eckert J. Epidemiology of Echinococcus multilocularis and E. granulosus in central Europe. Parassitologia. 1997 Dec. 39(4):337-44. [QxMD MEDLINE Link].
Eckert J, Jacquier P, Baumann D, Raeber PA. [Human echinococcosis in Switzerland, 1984-1992]. Schweiz Med Wochenschr. 1995 Oct 21. 125(42):1989-98. [QxMD MEDLINE Link].
Eiermann TH, Bettens F, Tiberghien P, Schmitz K, Beurton I, Bresson-Hadni S, et al. HLA and alveolar echinococcosis. Tissue Antigens. 1998 Aug. 52(2):124-9. [QxMD MEDLINE Link].
Etievent JP, Vuitton D, Allemand H, Weill F, Gandjbakhch I, Miguet JP. Pulmonary embolism from a parasitic cardiac clot secondary to hepatic alveolar echinococcosis. J Cardiovasc Surg (Torino). 1986 Nov-Dec. 27(6):671-4. [QxMD MEDLINE Link].
Feng X, Wen H, Zhang Z, Chen X, Ma X, Zhang J, et al. Dot immunogold filtration assay (DIGFA) with multiple native antigens for rapid serodiagnosis of human cystic and alveolar echinococcosis. Acta Trop. 2009 Oct 23. [QxMD MEDLINE Link].
Frei P, Misselwitz B, Prakash MK, Schoepfer AM, Prinz Vavricka BM, Müllhaupt B, et al. Late biliary complications in human alveolar echinococcosis are associated with high mortality. World J Gastroenterol. 2014 May 21. 20(19):5881-8. [QxMD MEDLINE Link]. [Full Text].
Gigandet S, Agache A, Parizet C, Weill F. [Venous study of the limbs with duplex Doppler and color Doppler. An iconographic review]. J Radiol. 1991 Jun-Jul. 72(6-7):341-8. [QxMD MEDLINE Link].
Giraudoux P, Craig PS, Delattre P, Bao G, Bartholomot B, Harraga S, et al. Interactions between landscape changes and host communities can regulate Echinococcus multilocularis transmission. Parasitology. 2003. 127 Suppl:S121-31. [QxMD MEDLINE Link].
Godot V, Harraga S, Beurton I, Deschaseaux M, Sarciron E, Gottstein B, et al. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions. Clin Exp Immunol. 2000 Sep. 121(3):484-90. [QxMD MEDLINE Link].
Godot V, Harraga S, Beurton I, Tiberghien P, Sarciron E, Gottstein B, et al. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype. Clin Exp Immunol. 2000 Sep. 121(3):491-8. [QxMD MEDLINE Link].
Godot V, Harraga S, Deschaseaux M, Bresson-Hadni S, Gottstein B, Emilie D, et al. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis. Eur Cytokine Netw. 1997 Dec. 8(4):401-8. [QxMD MEDLINE Link].
Godot V, Harraga S, Podoprigora G, Liance M, Bardonnet K, Vuitton DA. IFN alpha-2a protects mice against a helminth infection of the liver and modulates immune responses. Gastroenterology. 2003 May. 124(5):1441-50. [QxMD MEDLINE Link].
Gottstein B. Echinococcus multilocularis infection: immunology and immunodiagnosis. Adv Parasitol. 1992. 31:321-80. [QxMD MEDLINE Link].
Gottstein B. Molecular and immunological diagnosis of echinococcosis. Clin Microbiol Rev. 1992 Jul. 5(3):248-61. [QxMD MEDLINE Link].
Gottstein B. Purification and characterization of a specific antigen from Echinococcus multilocularis. Parasite Immunol. 1985 May. 7(3):201-12. [QxMD MEDLINE Link].
Gottstein B, Schantz PM, Wilson JF. Serological screening for Echinococcus multilocularis infections with ELISA. Lancet. 1985 May 11. 1(8437):1097-8. [QxMD MEDLINE Link].
Grenard P, Bresson-Hadni S, El Alaoui S, Chevallier M, Vuitton DA, Ricard-Blum S. Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis. J Hepatol. 2001 Sep. 35(3):367-75. [QxMD MEDLINE Link].
Harraga S, Godot V, Bresson-Hadni S, Pater C, Beurton I, Bartholomot B, et al. Clinical efficacy of and switch from T helper 2 to T helper 1 cytokine profile after interferon alpha2a monotherapy for human echinococcosis. Clin Infect Dis. 1999 Jul. 29(1):205-6. [QxMD MEDLINE Link].
Horton RJ. Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Trop. 1997 Apr 1. 64(1-2):79-93. [QxMD MEDLINE Link].
Horton RJ. Albendazole: a review of the pharmacology, pharmacokinetics, clinical efficacy and safety in hydatid disease. Uchino J, Sato N, eds. Alveolar Echinococcosis. Sapporo, Japan: Fuji Shoin; 1996. 261-97.
Ishikawa Y, Sako Y, Itoh S, Ohtake T, Kohgo Y, Matsuno T. Serological monitoring of progression of alveolar echinococcosis with multiorgan involvement by use of recombinant Em18. J Clin Microbiol. 2009 Oct. 47(10):3191-6. [QxMD MEDLINE Link]. [Full Text].
Ito A, Schantz PM, Wilson JF. Em18, a new serodiagnostic marker for differentiation of active and inactive cases of alveolar hydatid disease. Am J Trop Med Hyg. 1995 Jan. 52(1):41-4. [QxMD MEDLINE Link].
Ito A, Xiao N, Liance M, Sato MO, Sako Y, Mamuti W, et al. Evaluation of an enzyme-linked immunosorbent assay (ELISA) with affinity-purified Em18 and an ELISA with recombinant Em18 for differential diagnosis of alveolar echinococcosis: results of a blind test. J Clin Microbiol. 2002 Nov. 40(11):4161-5. [QxMD MEDLINE Link].
Kadry Z, Renner EC, Bachmann LM, Attigah N, Renner EL, Ammann RW, et al. Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis. Br J Surg. 2005 Sep. 92(9):1110-6. [QxMD MEDLINE Link].
Kapel CM, Torgerson PR, Thompson RC, Deplazes P. Reproductive potential of Echinococcus multilocularis in experimentally infected foxes, dogs, raccoon dogs and cats. Int J Parasitol. 2006 Jan. 36(1):79-86. [QxMD MEDLINE Link].
Kern P, Abboud P, Kern W, Stich A, Bresson-Hadni S, Guerin B, et al. Critical appraisal of nitazoxanide for the treatment of alveolar echinococcosis. Am J Trop Med Hyg. 2008. 79:119.
Kern P, Bardonnet K, Renner E, Auer H, Pawlowski Z, Ammann RW, et al. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis. 2003 Mar. 9(3):343-9. [QxMD MEDLINE Link].
Kern P, Frosch P, Helbig M, Wechsler JG, Usadel S, Beckh K, et al. Diagnosis of Echinococcus multilocularis infection by reverse-transcription polymerase chain reaction. Gastroenterology. 1995 Aug. 109(2):596-600. [QxMD MEDLINE Link].
Kern P, Wen H, Sato N, Vuitton DA, Gruener B, Shao Y. WHO classification of alveolar echinococcosis: principles and application. Parasitol Int. 2006. 55 Suppl:S283-7. [QxMD MEDLINE Link].
Knapp J, Bart JM, Giraudoux P, Glowatzki ML, Breyer I, Raoul F, et al. Genetic Diversity of the Cestode Echinococcus multilocularis in Red Foxes at a Continental Scale in Europe. PLoS Negl Trop Dis. 2009 Jun 9. 3(6):e452. [QxMD MEDLINE Link]. [Full Text].
Koch S, Bresson-Hadni S, Miguet JP, Crumbach JP, Gillet M, Mantion GA, et al. Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report. Transplantation. 2003 Mar 27. 75(6):856-63. [QxMD MEDLINE Link].
Kratzer W, Reuter S, Hirschbuehl K, Ehrhardt AR, Mason RA, Haenle MM, et al. Comparison of contrast-enhanced power Doppler ultrasound (Levovist) and computed tomography in alveolar echinococcosis. Abdom Imaging. 2005 May-Jun. 30(3):286-90. [QxMD MEDLINE Link].
Kreidl P, Allerberger F, Judmaier G, Auer H, Aspock H, Hall AJ. Domestic pets as risk factors for alveolar hydatid disease in Austria. Am J Epidemiol. 1998 May 15. 147(10):978-81. [QxMD MEDLINE Link].
Liance M, Bresson-Hadni S, Meyer JP, Houin R, Vuitton DA. Cellular immunity in experimental Echinococcus multilocularis infection. I. Sequential and comparative study of specific in vivo delayed-type hypersensitivity against E. multilocularis antigens in resistant and sensitive mice. Clin Exp Immunol. 1990 Nov. 82(2):373-7. [QxMD MEDLINE Link].
Liance M, Bresson-Hadni S, Vuitton DA, Lenys D, Carbillet JP, Houin R. Effects of cyclosporin A on the course of murine alveolar echinococcosis and on specific cellular and humoral immune responses against Echinococcus multilocularis. Int J Parasitol. 1992 Feb. 22(1):23-8. [QxMD MEDLINE Link].
Liance M, Janin V, Bresson-Hadni S, Vuitton DA, Houin R, Piarroux R. Immunodiagnosis of Echinococcus infections: confirmatory testing and species differentiation by a new commercial Western Blot. J Clin Microbiol. 2000 Oct. 38(10):3718-21. [QxMD MEDLINE Link].
Liance M, Vuitton DA, Guerret-Stocker S, Carbillet JP, Grimaud JA, Houin R. Experimental alveolar echinococcosis. Suitability of a murine model of intrahepatic infection by Echinococcus multilocularis for immunological studies. Experientia. 1984 Dec 15. 40(12):1436-9. [QxMD MEDLINE Link].
Lidove O, Chauveheid MP, Papo T, Vuitton DA, Piarroux R, Hernigou A, et al. Echinococcus multilocularis massive pericardial infection: late and dramatic improvement under albendazole therapy. Am J Med. 2005 Feb. 118(2):195-7. [QxMD MEDLINE Link].
Lin RY, Wang JH, Lu XM, Zhou XT, Mantion G, Wen H, et al. Components of the mitogen-activated protein kinase cascade are activated in hepatic cells by Echinococcus multilocularis metacestode. World J Gastroenterol. 2009 May 7. 15(17):2116-24. [QxMD MEDLINE Link]. [Full Text].
Macpherson CN, Bartholomot B, Frider B. Application of ultrasound in diagnosis, treatment, epidemiology, public health and control of Echinococcus granulosus and E. multilocularis. Parasitology. 2003. 127 Suppl:S21-35. [QxMD MEDLINE Link].
Malczewski A, Rocki B, Ramisz A, Eckert J. Echinococcus multilocularis (Cestoda), the causative agent of alveolar echinococcosis in humans: first record in Poland. J Parasitol. 1995 Apr. 81(2):318-21. [QxMD MEDLINE Link].
Martinek K, Kolarova L, Cerveny J, Andreas M. Echinococcus multilocularis (Cestoda: Taeniidae) in the Czech Republic: the first detection of metacestodes in a naturally infected rodent. Folia Parasitol (Praha). 1998. 45(4):332-3. [QxMD MEDLINE Link].
Mathis A, Deplazes P, Eckert J. An improved test system for PCR-based specific detection of Echinococcus multilocularis eggs. J Helminthol. 1996 Sep. 70(3):219-22. [QxMD MEDLINE Link].
Nicod L, Bresson-Hadni S, Vuitton DA, Emery I, Gottstein B, Auer H, et al. Specific cellular and humoral immune responses induced by different antigen preparations of Echinococcus multilocularis metacestodes in patients with alveolar echinococcosis. Parasite. 1994 Sep. 1(3):261-70. [QxMD MEDLINE Link].
Petavy AF, Tenora F, Deblock S, Sergent V. Echinococcus multilocularis in domestic cats in France. A potential risk factor for alveolar hydatid disease contamination in humans. Vet Parasitol. 2000 Jan. 87(2-3):151-6. [QxMD MEDLINE Link].
Pleydell DR, Yang YR, Danson FM, Raoul F, Craig PS, McManus DP. Landscape composition and spatial prediction of alveolar echinococcosis in southern ningxia, china. PLoS Negl Trop Dis. 2008. 2(9):e287. [QxMD MEDLINE Link]. [Full Text].
Rausch RL, Wilson JF, Schantz PM. A programme to reduce the risk of infection by Echinococcus multilocularis: the use of praziquantel to control the cestode in a village in the hyperendemic region of Alaska. Ann Trop Med Parasitol. 1990 Jun. 84(3):239-50. [QxMD MEDLINE Link].
Rausch RL, Wilson JF, Schantz PM, McMahon BJ. Spontaneous death of Echinococcus multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance. Am J Trop Med Hyg. 1987 May. 36(3):576-85. [QxMD MEDLINE Link].
Reuter S, Buck A, Grebe O, Nussle-Kugele K, Kern P, Manfras BJ. Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob Agents Chemother. 2003 Nov. 47(11):3586-91. [QxMD MEDLINE Link].
Reuter S, Buck A, Manfras B, Kratzer W, Seitz HM, Darge K. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology. 2004 Feb. 39(2):509-17. [QxMD MEDLINE Link].
Reuter S, Jensen B, Buttenschoen K, Kratzer W, Kern P. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother. 2000 Sep. 46(3):451-6. [QxMD MEDLINE Link].
Reuter S, Merkle M, Brehm K, Kern P, Manfras B. Effect of amphotericin B on larval growth of Echinococcus multilocularis. Antimicrob Agents Chemother. 2003 Feb. 47(2):620-5. [QxMD MEDLINE Link].
Reuter S, Nussle K, Kolokythas O, Haug U, Rieber A, Kern P, et al. Alveolar liver echinococcosis: a comparative study of three imaging techniques. Infection. 2001 May-Jun. 29(3):119-25. [QxMD MEDLINE Link].
Reuter S, Schirrmeister H, Kratzer W, Dreweck C, Reske SN, Kern P. Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. Clin Infect Dis. 1999 Nov. 29(5):1157-63. [QxMD MEDLINE Link].
Ricard-Blum S, Bresson-Hadni S, Guerret S, Grenard P, Volle PJ, Risteli L, et al. Mechanism of collagen network stabilization in human irreversible granulomatous liver fibrosis. Gastroenterology. 1996 Jul. 111(1):172-82. [QxMD MEDLINE Link].
Ricard-Blum S, Bresson-Hadni S, Vuitton DA, Ville G, Grimaud JA. Hydroxypyridinium collagen cross-links in human liver fibrosis: study of alveolar echinococcosis. Hepatology. 1992 Apr. 15(4):599-602. [QxMD MEDLINE Link].
Ricard-Blum S, Liance M, Houin R, Grimaud JA, Vuitton DA. Covalent cross-linking of liver collagen by pyridinoline increases in the course of experimental alveolar echinococcosis. Parasite. 1995 Jun. 2(2):113-8. [QxMD MEDLINE Link].
Sarciron EM, Bresson-Hadni S, Mercier M, Lawton P, Duranton C, Lenys D, et al. Antibodies against Echinococcus multilocularis alkaline phosphatase as markers for the specific diagnosis and the serological monitoring of alveolar echinococcosis. Parasite Immunol. 1997 Feb. 19(2):61-8. [QxMD MEDLINE Link].
Schantz PM. Tapeworms (cestodiasis). Gastroenterol Clin North Am. 1996 Sep. 25(3):637-53. [QxMD MEDLINE Link].
Schantz PM, Brandt FH, Dickinson CM, Allen CR, Roberts JM, Eberhard ML. Effects of albendazole on Echinococcus multilocularis infection in the Mongolian jird. J Infect Dis. 1990 Dec. 162(6):1403-7. [QxMD MEDLINE Link].
Schantz PM, Chai J, Craig PS. Epidemiology and control of hydatid disease. Thompson RCA, Lymbery AJ, eds. Echinococcus and Hydatid Disease. Wallingford, United Kingdom: Cab International; 1995. 233-331.
Schelling U, Frank W, Will R, Romig T, Lucius R. Chemotherapy with praziquantel has the potential to reduce the prevalence of Echinococcus multilocularis in wild foxes (Vulpes vulpes). Ann Trop Med Parasitol. 1997 Mar. 91(2):179-86. [QxMD MEDLINE Link].
Schmitt M, Saucy F, Wyborn S, Gottstein B. [Infestation of water voles (Arvicola terrestris) with metacestodes of Echinococcus multilocularis in the canton Freiburg (Switzerland)]. Schweiz Arch Tierheilkd. 1997. 139(2):84-93. [QxMD MEDLINE Link].
Schweiger A, Ammann RW, Candinas D, Clavien PA, Eckert J, Gottstein B. Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis. 2007 Jun. 13(6):878-82. [QxMD MEDLINE Link]. [Full Text].
Stettler M, Fink R, Walker M, Gottstein B, Geary TG, Rossignol JF, et al. In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes. Antimicrob Agents Chemother. 2003 Feb. 47(2):467-74. [QxMD MEDLINE Link].
Stettler M, Rossignol JF, Fink R, Walker M, Gottstein B, Merli M, et al. Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity. Int J Parasitol. 2004 Apr. 34(5):615-24. [QxMD MEDLINE Link].
Sturm D, Menzel J, Gottstein B, Kern P. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect Immun. 1995 May. 63(5):1688-97. [QxMD MEDLINE Link].
Suzuki K, Uchino J, Sato N. Development and efficacy of mass screening of alveolar echinococcosis. Uchino J, Sato N, eds. Alveolar Echinococcosis. Sapporo, Japan: Fuji Shoin; 1996. 213-7.
Thompson RCA. Biology and systematics of Echinococcus. Thompson RC, Lymbery AJ, eds. Echinococcus and Hydatid Disease. Wallingford, United Kingdom: Cab International; 1995. 1-50.
Viel JF, Giraudoux P, Abrial V, Bresson-Hadni S. Water vole (Arvicola terrestris scherman) density as risk factor for human alveolar echinococcosis. Am J Trop Med Hyg. 1999 Oct. 61(4):559-65. [QxMD MEDLINE Link].
Vogel J, Görich J, Kramme E, Merkle E, Sokiranski R, Kern P. Alveolar echinococcosis of the liver: percutaneous stent therapy in Budd-Chiari syndrome. Gut. 1996 Nov. 39(5):762-4. [QxMD MEDLINE Link].
Vogel M, Muller N, Gottstein B, Flury K, Eckert J, Seebeck T. Echinococcus multilocularis: characterization of a DNA probe. Acta Trop. 1990 Dec. 48(2):109-16. [QxMD MEDLINE Link].
Vuitton D. Alveolar echinococcosis of the liver: a parasitic disease in search of a treatment. Hepatology. 1990 Sep. 12(3 Pt 1):617-8. [QxMD MEDLINE Link].
Vuitton DA. Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus?. Expert Rev Anti Infect Ther. 2009 Mar. 7(2):145-9. [QxMD MEDLINE Link].
Vuitton DA. Echinococcosis and allergy. Clin Rev Allergy Immunol. 2004 Apr. 26(2):93-104. [QxMD MEDLINE Link].
Vuitton DA. New trends in the treatment of echinococcosis. Helminthologia. 1999. 36:167-70.
Vuitton DA. The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite?. Acta Trop. 2003 Feb. 85(2):119-32. [QxMD MEDLINE Link].
Vuitton DA, Bresson-Hadni S, Laroche L, Kaiserlian D, Guerret-Stocker S, Bresson JL, et al. Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clin Exp Immunol. 1989 Oct. 78(1):67-74. [QxMD MEDLINE Link].
Vuitton DA, Bresson-Hadni S, Lenys D, Flausse F, Liance M, Wattre P, et al. IgE-dependent humoral immune response in Echinococcus multilocularis infection: circulating and basophil-bound specific IgE against Echinococcus antigens in patients with alveolar echinococcosis. Clin Exp Immunol. 1988 Feb. 71(2):247-52. [QxMD MEDLINE Link].
Vuitton DA, Bresson-Hadni S, Liance M, Meyer JP, Giraudoux P, Lenys D. [Human alveolar echinococcosis. Epidemiologic hazard or immunologic incident?]. Gastroenterol Clin Biol. 1990. 14(2):124-30. [QxMD MEDLINE Link].
Vuitton DA, Guerret-Stocker S, Carbillet JP, Mantion G, Miguet JP, Grimaud JA. Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis. Z Parasitenkd. 1986. 72(1):97-104. [QxMD MEDLINE Link].
Vuitton DA, Lasségue A, Miguet JP, Hervé P, Barale T, Seillés E. Humoral and cellular immunity in patients with hepatic alveolar echinococcosis. A 2 year follow-up with and without flubendazole treatment. Parasite Immunol. 1984 Jul. 6(4):329-40. [QxMD MEDLINE Link].
Vuitton DA, Zhang SL, Yang Y, Godot V, Beurton I, Mantion G, et al. Survival strategy of Echinococcus multilocularis in the human host. Parasitol Int. 2006. 55 Suppl:S51-5. [QxMD MEDLINE Link].
Vuitton DA, Zhou H, Bresson-Hadni S, Wang Q, Piarroux M, Raoul F, et al. Epidemiology of alveolar echinococcosis with particular reference to China and Europe. Parasitology. 2003. 127 Suppl:S87-107. [QxMD MEDLINE Link].
Walker M, Rossignol JF, Torgerson P, Hemphill A. In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes. J Antimicrob Chemother. 2004 Sep. 54(3):609-16. [QxMD MEDLINE Link].
Wang Q, Vuitton DA, Qiu J, Giraudoux P, Xiao Y, Schantz PM, et al. Fenced pasture: a possible risk factor for human alveolar echinococcosis in Tibetan pastoralist communities of Sichuan, China. Acta Trop. 2004 May. 90(3):285-93. [QxMD MEDLINE Link].
Wang Q, Vuitton DA, Xiao Y, Budke CM, Campos-Ponce M, Schantz PM, et al. Pasture types and Echinococcus multilocularis, Tibetan communities. Emerg Infect Dis. 2006 Jun. 12(6):1008-10. [QxMD MEDLINE Link].
Wen H, Bresson-Hadni S, Vuitton DA, Lenys D, Yang BM, Ding ZX, et al. Analysis of immunoglobulin G subclass in the serum antibody responses of alveolar echinococcosis patients after surgical treatment and chemotherapy as an aid to assessing the outcome. Trans R Soc Trop Med Hyg. 1995 Nov-Dec. 89(6):692-7. [QxMD MEDLINE Link].
Wen H, Craig PS, Ito A, Vuitton DA, Bresson-Hadni S, Allan JC, et al. Immunoblot evaluation of IgG and IgG-subclass antibody responses for immunodiagnosis of human alveolar echinococcosis. Ann Trop Med Parasitol. 1995 Oct. 89(5):485-95. [QxMD MEDLINE Link].
Wen H, New RR, Muhmut M, Wang JH, Wang YH, Zhang JH, et al. Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine. Parasitology. 1996 Aug. 113 (Pt 2):111-21. [QxMD MEDLINE Link].
Yamasaki H, Nakao M, Nakaya K, Schantz PM, Ito A. Genetic analysis of Echinococcus multilocularis originating from a patient with alveolar echinococcosis occurring in Minnesota in 1977. Am J Trop Med Hyg. 2008 Aug. 79(2):245-7. [QxMD MEDLINE Link].
Yang YR, Ellis M, Sun T, Li Z, Liu X, Vuitton DA. Unique family clustering of human echinococcosis cases in a chinese community. Am J Trop Med Hyg. 2006 Mar. 74(3):487-94. [QxMD MEDLINE Link].
Yang YR, Liu XZ, Vuitton DA, Bartholomot B, Wang YH, Ito A. Simultaneous alveolar and cystic echinococcosis of the liver. Trans R Soc Trop Med Hyg. 2006 Jun. 100(6):597-600. [QxMD MEDLINE Link].
Yang YR, Sun T, Li Z, Li X, Zhao R, Cheng L, et al. Echinococcosis, Ningxia, China. Emerg Infect Dis. 2005 Aug. 11(8):1314-6. [QxMD MEDLINE Link].
Yang YR, Vuitton DA, Jones MK, Craig PS, McManus DP. Brain metastasis of alveolar echinococcosis in a hyperendemic focus of Echinococcus multilocularis infection. Trans R Soc Trop Med Hyg. 2005 Dec. 99(12):937-41. [QxMD MEDLINE Link].
Zhang S, Hüe S, Sène D, Penfornis A, Bresson-Hadni S, Kantelip B, et al. Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites?. J Infect Dis. 2008 May 1. 197(9):1341-9. [QxMD MEDLINE Link].
Zhang S, Penfornis A, Harraga S, Chabod J, Beurton I, Bresson-Hadni S, et al. Polymorphisms of the TAP1 and TAP2 genes in human alveolar echinococcosis. Eur J Immunogenet. 2003 Apr. 30(2):133-9. [QxMD MEDLINE Link].
Zhou HX, Wen H, Wang YH, Delattre P, Quere JP, Vuitton DA, et al. Experimental susceptibility of Spermophilus erythrogenys to Echinococcus multilocularis. Ann Trop Med Parasitol. 1998 Apr. 92(3):335-7. [QxMD MEDLINE Link].
